TY - JOUR
T1 - Non-inferiority testing for qualitative microbiological methods
T2 - Assessing and improving the approach in USP 1223
AU - IJzerman-Boon, Pieta C.
AU - Manju, Md Abu
AU - van den Heuvel, Edwin R.
N1 - Publisher Copyright:
© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.
PY - 2022/11/2
Y1 - 2022/11/2
N2 - The United States Pharmacopoeia (USP) presents two approaches for showing non-inferiority of an alternate qualitative microbiological method versus a compendial method. One approach compares the positive rates for the alternate and compendial methods at one spike level, while the other one compares multiple most probable number (MPN) estimates from a multi-spike design using a t-test. In this paper, we discuss these approaches under certain assumptions and propose a third approach that can be used for both single and multiple dilutions, which we call the generalized MPN (gMPN) approach. Simulations, using Poisson distributed numbers of microorganisms in test samples, confirm that the USP approach based on rates is not suitable, that the USP approach based on MPNs is appropriate for non-inferiority, but the gMPN approach outperforms the MPN-based approach and is therefore recommended.
AB - The United States Pharmacopoeia (USP) presents two approaches for showing non-inferiority of an alternate qualitative microbiological method versus a compendial method. One approach compares the positive rates for the alternate and compendial methods at one spike level, while the other one compares multiple most probable number (MPN) estimates from a multi-spike design using a t-test. In this paper, we discuss these approaches under certain assumptions and propose a third approach that can be used for both single and multiple dilutions, which we call the generalized MPN (gMPN) approach. Simulations, using Poisson distributed numbers of microorganisms in test samples, confirm that the USP approach based on rates is not suitable, that the USP approach based on MPNs is appropriate for non-inferiority, but the gMPN approach outperforms the MPN-based approach and is therefore recommended.
KW - Binomial detection
KW - detection proportion
KW - limit of detection
KW - microbiological validation
KW - most probable number
KW - sterility tests
KW - Humans
KW - Microbiological Techniques
UR - http://www.scopus.com/inward/record.url?scp=85139090908&partnerID=8YFLogxK
U2 - 10.1080/10543406.2022.2065498
DO - 10.1080/10543406.2022.2065498
M3 - Article
C2 - 36131516
AN - SCOPUS:85139090908
SN - 1054-3406
VL - 32
SP - 915
EP - 941
JO - Journal of Biopharmaceutical Statistics
JF - Journal of Biopharmaceutical Statistics
IS - 6
ER -